Amgen AMGN
NASDAQ AMGN
$439.33 +8.12 (+1.88%)
At close: Aug 21, 2026 · 4:00 PM EDT

Amgen (AMGN) Goodwill & Intangibles (2009 - 2026)

Amgen (AMGN) posted quarterly Goodwill & Intangibles of $40.1 billion for Q1 2026, up 70.84% year-over-year from $23.4 billion in Q1 2025, and down 2.2% quarter-over-quarter from $41.0 billion in Q4 2025.

Amgen (AMGN) Goodwill & Intangibles (2009 - 2026) Analysis & Trends

Amgen's Goodwill & Intangibles history runs 18 years deep, the most recent figure standing at $40.1 billion for Q1 2026.

  • In Q1 2026, Goodwill & Intangibles rose 70.84% year-over-year to $40.1 billion; the TTM figure through Mar 2026 stood at $40.1 billion (up 70.84% YoY), while the FY2025 annual figure was $41.0 billion, down 11.61% from the prior year.
  • Goodwill & Intangibles for Q1 2026 stood at $40.1 billion, down from $41.0 billion in the prior quarter.
  • The five-year high for Goodwill & Intangibles was $51.3 billion in Q4 2023, with the low at $19.0 billion in Q2 2025.
  • The 5-year median for Goodwill & Intangibles is $31.6 billion (2022), against an average of $36.3 billion.
  • The sharpest annual moves came in 2025 and 2026: Goodwill & Intangibles plunged 61.01% in 2025, then soared 70.84% in 2026.
  • Amgen's Goodwill & Intangibles stood at $31.6 billion in 2022, then surged by 62.2% to $51.3 billion in 2023, then fell by 9.62% to $46.3 billion in 2024, then fell by 11.61% to $41.0 billion in 2025, then retreated by 2.2% to $40.1 billion in 2026.
  • Business Quant data shows AMGN's Goodwill & Intangibles at $40.1 billion in Q1 2026, $41.0 billion in Q4 2025, and $41.8 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn
10 Sanofi 55.07 Bn 47.69 Bn 10.79 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 39.16 Bn
Mar 31, 2026 40.05 Bn
Dec 31, 2025 40.96 Bn
Sep 30, 2025 41.82 Bn
Jun 30, 2025 19.02 Bn
Mar 31, 2025 23.45 Bn
Dec 31, 2024 46.34 Bn
Sep 30, 2024 47.58 Bn
Jun 30, 2024 48.79 Bn
Mar 31, 2024 49.94 Bn
Dec 31, 2023 51.27 Bn
Sep 30, 2023 28.66 Bn
Jun 30, 2023 30.16 Bn
Mar 31, 2023 30.92 Bn
Dec 31, 2022 31.61 Bn
Sep 30, 2022 28.11 Bn
Jun 30, 2022 28.79 Bn
Mar 31, 2022 29.46 Bn
Dec 31, 2021 30.07 Bn
Sep 30, 2021 29.32 Bn